Stem Cells Spin S.A. (WSE:SCS)
0.3640
-0.0640 (-14.95%)
At close: Jan 23, 2026
Stem Cells Spin Revenue
Stem Cells Spin had revenue of 32.80K PLN in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to 115.74K, down -30.59% year-over-year. In the year 2024, Stem Cells Spin had annual revenue of 54.28K, down -87.06%.
Revenue (ttm)
115.74K
Revenue Growth
-30.59%
P/S Ratio
130.01
Revenue / Employee
115.74K
Employees
1
Market Cap
15.05M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 54.28K | -365.04K | -87.06% |
| Dec 31, 2023 | 419.32K | 170.96K | 68.84% |
| Dec 31, 2022 | 248.36K | -277.56K | -52.78% |
| Dec 31, 2021 | 525.92K | 257.60K | 96.00% |
| Dec 31, 2020 | 268.32K | -313.83K | -53.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.34B |
| Diagnostyka | 2.30B |
| Synektik Spólka Akcyjna | 681.60M |
| Voxel | 568.83M |
| Zortrax | 9.06M |
| InventionMed | 2.28M |
| genXone | 2.03M |
| Nestmedic | 1.05M |